Gene regulatory role of vIRF1 in KSHV infection
vIRF1在KSHV感染中的基因调控作用
基本信息
- 批准号:10665555
- 负责人:
- 金额:$ 4.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-16 至 2024-08-15
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAntiviral ResponseAntiviral TherapyB-Cell LymphomasBindingBiologicalBiological AssayC-terminalCell CommunicationCell ProliferationCellsChIP-seqChromatinClinical ResearchCytokine ReceptorsDNADNA BindingDNA Binding DomainDNA SequenceDNA Tumor VirusesDataDentistryDentistsDevelopmentEP300 geneEnvironmentEpigenetic ProcessEpithelial CellsEtiologyFloridaFoundationsGene ExpressionGene Expression RegulationGene TargetingGenesGenetic TranscriptionGenomic approachGingivaGoalsGrowthHerpesviridae InfectionsHistone AcetylationHumanHuman Herpesvirus 8Immune responseIndividualInfectionInterferonsKaposi SarcomaKnock-outLuciferasesLyticLytic PhaseMediatingMentorshipMetabolismMethodsMorphogenesisN-terminalNuclearNuclear Localization SignalOncogenicOncogenic VirusesOralOral cavityPalate Kaposi&aposs SarcomaPathogenesisPathway interactionsPersonsPlayPopulationProteinsPublicationsRegulationRegulator GenesReporterRepressionResearchResearch TrainingResponse ElementsRoleRouteSalivaSalivaryScientistSequence HomologySexual TransmissionSignal PathwayTerminator CodonTestingTrainingTraining ProgramsTranscriptional RegulationUniversitiesViralViral GenesViral PathogenesisVirionVirusVirus Replicationcareerchromatin immunoprecipitationchronic infectionclinical trainingcofactorcollegecytokineepidemiology studyexperimental studygene inductionhistone acetyltransferaseinhibitormutantnew therapeutic targetoral biologyoral cavity epitheliumoral infectionpathogenpreventpromoterprotein complexprotein expressionrecruitsmall hairpin RNAtranscription factortranscriptome sequencingtransmission processtumorigenesisviral interferon regulatory factorviral interferon regulatory factor-1viral transmissionvirology
项目摘要
Abstract
Infection of humans by the oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV) starts in the oral cavity
by replicating in oral epithelial cells. Regulation of lytic KSHV infection of the oral epithelium is still poorly
understood, which hampers the development of effective antiviral therapies to block KSHV transmission. One of
the unique features of KSHV is that it encodes four different viral interferon regulatory factors (vIRFs), which are
homologous with cellular interferon regulatory factors (IRFs). One of them is vIRF1, which is expressed the
earliest and at the highest level during KSHV infection and is used by KSHV to control many different aspects of
the pathogenesis such as blocking antiviral response or stimulating oncogenesis and the growth of infected cells.
While the function of vIRF1 in the inhibition of different immune response signaling pathways have been studied
in detail, the transcriptional function of vIRF1 in the regulation of both KSHV and host cellular genes that are
important in viral pathogenesis is still poorly understood. vIRF1 is 449 amino acid long protein. It has a putative
DNA-binding domain (DBD), which also contains a nuclear localization signal (NLS), and it has a C-terminal IRF
interaction domain (IAD). My preliminary experiments revealed that the DNA-binding domain (DBD) of vIRF1 is
required for vIRF1-mediated host and viral gene induction, indicating vIRF1 induces both viral and host genes
by binding to their promoters. Our research group has also identified the viral and host proteins interacting with
vIRF1 by protein complex purification. This revealed the interaction of vIRF1 with histone acetyltransferases
(HATs) that often serve as co-factors for various DNA-binding transcription factors in gene induction. I
hypothesize that vIRF1 can bind to specific host and viral promoters and uses HATs to induce their
corresponding genes to enhance the lytic KSHV infection in oral epithelial cells. I propose two specific aims to
test my hypothesis. Aim 1 focuses on identifying the host genes that are directly targeted by vIRF1 in the absence
of the other vIRFs in KSHV-infected oral epithelial cells. Aim 2 is to determine the vIRF1 response element in
vIRF1 target KSHV promoters that is required for vIRF1-mediated promoter activation. The completion of this
project will provide in-depth training in virology, epigenetics and genomics approaches as these methods will be
used to elucidate this critical host pathogen interactions. The Comprehensive Training Program in Oral Biology
at the University of Florida College of Dentistry will provide me an outstanding environment to prepare me for a
career as a dentist scientist by providing personalized mentorship and excellent clinical and research training.
摘要
致癌性卡波西肉瘤相关疱疹病毒(KSHV)对人类的感染始于口腔
通过在口腔上皮细胞中复制。口腔上皮细胞的溶解性KSHV感染的调控仍然很差
这阻碍了开发有效的抗病毒疗法来阻断KSHV传播。之一
KSHV的独特之处在于它编码四种不同的病毒干扰素调节因子(vIRF),
与细胞干扰素调节因子(IRFs)同源。其中之一是vIRF1,它表达为
在KSHV感染期间最早和最高水平,并被KSHV用于控制许多不同方面的疾病。
发病机制如阻断抗病毒反应或刺激肿瘤发生和感染细胞的生长。
vIRF 1在不同免疫应答信号通路中的抑制作用已被研究
详细地说,vIRF1在KSHV和宿主细胞基因调节中的转录功能,
在病毒发病机制中的重要作用仍然知之甚少。vIRF 1是449个氨基酸长的蛋白质。它有一个假定的
DNA结合结构域(DBD),也含有核定位信号(NLS),C端有一个IRF
相互作用域(IAD)。我的初步实验表明,vIRF1的DNA结合结构域(DBD)是
vIRF1介导的宿主和病毒基因诱导所需,表明vIRF1诱导病毒和宿主基因
通过与它们的启动子结合。我们的研究小组还确定了病毒和宿主蛋白质相互作用,
通过蛋白复合物纯化vIRF1。这揭示了vIRF1与组蛋白乙酰转移酶的相互作用
在基因诱导中,HAT通常作为各种DNA结合转录因子的辅因子。我
假设vIRF1可以结合特异性宿主和病毒启动子,并利用HAT诱导其
相应的基因来增强口腔上皮细胞中的裂解性KSHV感染。我提出两个具体目标,
验证我的假设目的1侧重于鉴定在缺乏vIRF1的情况下vIRF1直接靶向的宿主基因。
KSHV感染的口腔上皮细胞中其他vIRF的表达。目的2是确定vIRF1反应元件,
vIRF1靶向vIRF1介导的启动子激活所需的KSHV启动子。完成这一
该项目将提供病毒学、表观遗传学和基因组学方法方面的深入培训,因为这些方法将
用于阐明这种关键的宿主病原体相互作用。口腔生物学综合训练计划
在佛罗里达大学牙科学院将为我提供一个出色的环境,为我准备一个
通过提供个性化的指导和优秀的临床和研究培训,成为牙医科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seung Jin Jang其他文献
Seung Jin Jang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seung Jin Jang', 18)}}的其他基金
Gene regulatory role of vIRF1 in KSHV infection
vIRF1在KSHV感染中的基因调控作用
- 批准号:
10464138 - 财政年份:2022
- 资助金额:
$ 4.76万 - 项目类别:
相似海外基金
Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
- 批准号:
494286 - 财政年份:2023
- 资助金额:
$ 4.76万 - 项目类别:
Operating Grants
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10364056 - 财政年份:2022
- 资助金额:
$ 4.76万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10621913 - 财政年份:2022
- 资助金额:
$ 4.76万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10373627 - 财政年份:2022
- 资助金额:
$ 4.76万 - 项目类别:
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10553146 - 财政年份:2022
- 资助金额:
$ 4.76万 - 项目类别:
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection
AMPK 和 Hippo 信号传导之间的相互作用调节眼部对寨卡病毒感染的抗病毒反应
- 批准号:
10322026 - 财政年份:2021
- 资助金额:
$ 4.76万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE介导的单核细胞抗病毒反应途径的调节机制
- 批准号:
10640247 - 财政年份:2021
- 资助金额:
$ 4.76万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE 介导的单核细胞抗病毒反应途径调节机制
- 批准号:
10438876 - 财政年份:2021
- 资助金额:
$ 4.76万 - 项目类别:
Antiviral response coupled with transposon derepression in Alzheimer's disease and aging
抗病毒反应与转座子去抑制在阿尔茨海默病和衰老中的作用
- 批准号:
10629440 - 财政年份:2021
- 资助金额:
$ 4.76万 - 项目类别:
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
增强子样启动子及其编码lncRNA对粘膜IRF1/IFN-III抗病毒反应的表观遗传控制
- 批准号:
10373575 - 财政年份:2021
- 资助金额:
$ 4.76万 - 项目类别: